Flamel Technologies (FLML) 13.37 $FLML Flamel

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Flamel Technologies (FLML) 13.37 $FLML

Flamel Technologies Hires Vice President of Sales
Marketwired - Wed Aug 31, 3:03PM CDT
LYON, FRANCE--(Marketwired - Aug 31, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that Mark W. Elrod has joined the Company as Vice President, Sales. Mr. Elrod will be responsible for managing sales across all of the Company's commercialized products.
FLML: 13.37 (unch)

21.5% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Fri Aug 26, 1:07AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on July 7th, 2016 at $11.26. In approximately 2 months, Flamel Technologies has returned 21.46% as of today's recent price of $13.67.
FLML: 13.37 (unch)

Flamel Technologies Shares Up 25.0% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Thu Aug 18, 1:36PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on July 7th, 2016 at $11.26. In approximately 1 month, Flamel Technologies has returned 25.01% as of today's recent price of $14.07.
FLML: 13.37 (unch)

Flamel Technologies Launches Akovaz(TM)
Marketwire Canada - Fri Aug 12, 6:32AM CDT
LYON, FRANCE--(Marketwired - Aug 12, 2016) - Flamel Technologies (NASDAQ: FLML) today announced the launch of Akovaz™, its formulation of ephedrine sulfate for injection, which received approval from the U.S. Food and Drug Administration (FDA) on April 29, 2016. Ephedrine sulfate (50 mg/mL) is a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings.
FLML: 13.37 (unch)

Flamel Technologies Announces Shareholder Approval of Cross-Border Merger
Marketwired - Fri Aug 12, 6:30AM CDT
Company to Reincorporate in Ireland
FLML: 13.37 (unch)

Flamel Technologies Reports Second Quarter 2016 Results
Marketwire Canada - Mon Aug 08, 6:30AM CDT
Total Revenues of $38.9 Million; 2016 Revenue Guidance Increased to $125 to $140 Million; Akovaz™ to Launch in August 2016
FLML: 13.37 (unch)

Flamel Technologies to Present at Two Upcoming Investor Conferences
Marketwired - Wed Jun 01, 6:30AM CDT
LYON, FRANCE--(Marketwired - Jun 1, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that management will present at two upcoming investor conferences:
FLML: 13.37 (unch)

Flamel Technologies Reports First Quarter 2016 Results
Marketwire Canada - Mon May 09, 6:30AM CDT
Total Revenues of $36.2 Million; Adjusted Net Income of $1.6 Million and Adjusted Diluted EPS of $0.04; Adjusted EBITDA of $11.8 Million; Cash Flow From Operations of $22.5 Million
FLML: 13.37 (unch)

Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML
Zacks Equity Research - Zacks Investment Research - Fri May 06, 9:19AM CDT
However, a few companies are still yet to report quarterly numbers. Let's see what we can expect from a few drug stocks reporting earnings early next week.
BIIB: 305.63 (unch), ABT: 42.02 (unch), JNJ: 119.34 (unch), FLML: 13.37 (unch), IRWD: 13.34 (unch), GILD: 78.38 (unch), AMGN: 170.06 (unch), FGEN: 17.31 (-0.37), ENTA: 21.99 (unch), NVS: 78.77 (unch)

Flamel Technologies to Report First Quarter 2016 Results
Marketwired - Mon May 02, 3:05PM CDT
Flamel Technologies (NASDAQ: FLML) today announced that the Company will report its financial results for the first quarter ended March 31, 2016 on Monday, May 9, 2016, before the market open. A conference call to discuss these results has been scheduled for Monday, May 9, 2016 at 10:00 a.m. ET. A question and answer period will follow management's prepared remarks.
FLML: 13.37 (unch)

Flamel Technologies Receives FDA Approval of Akovaz(TM)
Marketwired - Mon May 02, 6:30AM CDT
Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's New Drug Application (NDA) for Akovaz(TM) (ephedrine sulfate), a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings. Flamel obtained NDA approval for Akovaz as scheduled on April 29 and is the first to receive approval from the FDA for ephedrine sulfate. Flamel expects to launch Akovaz during the third quarter 2016 in a strength of 50 mg/mL.
FLML: 13.37 (unch)

Flamel Technologies to Present at Upcoming Investor Conferences
Marketwired - Fri Apr 22, 3:05PM CDT
Flamel Technologies (NASDAQ: FLML) today announced that management will present at two upcoming investor conferences. Michael Anderson, Chief Executive Officer, and Mike Kanan, Chief Financial Officer, are scheduled to present at the following:
FLML: 13.37 (unch)

Flamel Technologies Files Special Protocol Assessment for Once Nightly Sodium Oxybate
Marketwired - Thu Mar 31, 7:00AM CDT
Flamel Technologies (NASDAQ: FLML) today announced that it has filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for the pivotal Phase III study of its once nightly Micropump(TM) based sodium oxybate product. The SPA will provide the FDA an opportunity to review and comment on the company's planned study design, and once accepted, offers general acknowledgement by the FDA that the trial's design, clinical endpoints and statistical analyses are acceptable and support the scientific and regulatory requirements associated with the product.
FLML: 13.37 (unch)

Biotech Sector Report Analyst Coverage Focusing on Upcoming FDA Decisions
ACCESSWIRE - Mon Mar 28, 7:01AM CDT
NEW YORK, NY / ACCESSWIRE / March 28, 2016 / DURECT Corporation (NASDAQ: DRRX), Genocea Biosciences Inc. (NASDAQ: GNCA), Flamel Technologies SA (NASDAQ: FLML), and Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) are four tickers in the biotech space currently suffering due to the overall poor market sentiment towards the space. The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index is down 18% so far in 2016, and is now off about 30% since its July peak. This fall in market value has led to potential opportunities for big players in the space to pick up valuable assets are very low prices. While large drugmakers have hardly been exempt from the pain, the selloff should present a chance for them to find some cheap deals. Additionally, the four companies described here are expecting results from the FDA which may lead to even more upside for the junior biotech sector.
FLML: 13.37 (unch), VNDA: 15.38 (-0.34), GNCA: 5.36 (-0.03), DRRX: 1.67 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 77

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 125

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 44

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 92

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 316

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 233

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

BJ's Wholesale Club Exceeds Expectations with Q4 Earnings

Updated Category News Views 131

BJ's Wholesale Club Achieves Impressive Q4 Results BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has delivered a noteworthy performance in its latest financial results, showcasing resilience and growth in a competitive market. The company's fourth-quarter performance has not only exceeded expectations but also highlighted significant strengths in key operational areas....

Continue Reading
Elemeno Health Appoints Tim Coulter as New CEO for Growth

Updated Category News Views 433

Elemeno Health Welcomes Tim Coulter as New CEO Elemeno Health, a leader in microlearning solutions for healthcare staff, has made a significant announcement regarding its leadership. The company is thrilled to introduce Tim Coulter as its new Chief Executive Officer. With an impressive track record spanning over two decades in health technology and enterprise software,...

Continue Reading
Emerging Trends and Insights in the Amber Glass Packaging Market

Updated Category News Views 152

Growth and Innovation in Amber Glass Packaging The global amber glass packaging market has displayed strong resilience and growth potential. Recent studies indicate that this market, valued at USD 8.46 billion, is projected to reach USD 13.15 billion, indicating a robust compound annual growth rate (CAGR). This surge is driven by the multidimensional advantages of amber...

Continue Reading
FiEE, Inc. Celebrates Trading Resumption on Nasdaq as MINM

Updated Category News Views 273

FiEE, Inc. Announces Trading Resumption on Nasdaq The technology-driven company FiEE, Inc. is excited to share that it will resume trading on the Nasdaq under the existing symbol "MINM". This significant milestone follows a successful hearing with the Nasdaq Hearings Panel, which led to the decision to reinstate trading on the Nasdaq Capital Market. Details of the Trading...

Continue Reading
Vera Therapeutics Expands Talent with Inducement Awards

Updated Category News Views 209

Vera Therapeutics Expands Talent with Inducement Awards Vera Therapeutics, Inc. (Nasdaq: VERA) has recently taken a significant step towards enhancing its workforce by granting inducement awards. These awards, which were declared by the Compensation Committee on January 8, have been established to attract and retain six new employees. The inducement awards include a...

Continue Reading